返回 Agenda
Session Chair(s)
Angelika Joos, MPHARM
Executive Director, Science & Regulatory Policy
MSD, Belgium
Learning Objective : - Understanding of the content of the proposals to revise the CT legislation - Identify the key issues from key stakeholders that are to be addressed during the legislative procedure
Speaker(s)
Commission Objectives and Observation in the Current Debate
Stefan Fuehring
European Commission, Belgium
Administrator
Industry Perspective on the Proposal and Practical Implications
Nick Sykes, MS
EFPIA, Belgium
Policy Advisor, Regulatory Strategy
Regulator's View on the Legal Proposal and the Practical Implications
Greet Musch, PHD
FAMHP, Belgium
strategic adviser
Panel Discussion
Genevieve Michaux, LLM
King & Spalding International LLP, Belgium
Partner, Life Sciences